Concepedia

Keith A. Betts

KA

Statistics

Publications

48

Citations

2K

H-Index

23

Active since

2008

Affiliations

Analysis Group (United States)(Current)

AbbVie (United States)

Bristol-Myers Squibb (United States)

AstraZeneca (United States)

Takeda (United States)

Keith A. Betts is an author at Analysis Group (United States) specializing in medicine, rheumatoid arthritis, and rheumatology.

ORCID

Top concepts

Publications per year

2008–2023

48

Publications

48

Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research

James Signorovitch, Vanja Sikirica, M. Haim Erder et al. · Value in Health · 2012 · 461 citations · Full text

, , +12

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial

Meletios Α. Dimopoulos, Sagar Lonial, Keith A. Betts et al. · Cancer · 2018 · 139 citations · Full text

Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer

David Waterhouse, Jenny Lam, Keith A. Betts et al. · Lung Cancer · 2021 · 134 citations · Full text

The prevalence of hyperkalemia in the United States

Keith A. Betts, J. Michael Woolley, Fan Mu et al. · Current Medical Research and Opinion · 2018 · 88 citations

Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials

John D. Sheppard, Avani Joshi, Keith A. Betts et al. · JAMA Ophthalmology · 2017 · 80 citations · Full text

Rows per page

1–5 of 48